wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37604501-6381DFC9-BA05-4E9F-BD35-518CA51C0B39
Q37604501-6381DFC9-BA05-4E9F-BD35-518CA51C0B39
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-6381DFC9-BA05-4E9F-BD35-518CA51C0B39
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P2093
Q37604501-6381DFC9-BA05-4E9F-BD35-518CA51C0B39
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-6381DFC9-BA05-4E9F-BD35-518CA51C0B39
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b686291756c9ab815303fcfa1158383bf83d0b0
P1545
12
http://www.w3.org/2001/XMLSchema#string
P2093
Douglas Schlichting
http://www.w3.org/2001/XMLSchema#string